Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT03468127 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Meta-analysis of 46 FDA Identified Studies on Lipid Markers

Start date: March 7, 2018
Phase: N/A
Study type: Observational

The FDA have revised the data on soy and concluded that a heart health claim is no longer justified based on more recent studies. They are allowing and established panel for public input. The selected studies have not been meta-analyzed, therefore we will conduct a meta-analysis of the 46 FDA selected studies to assess the effect of soy protein on surrogate markers of cardiovascular disease (LDL-C and TC).

NCT ID: NCT03466333 Completed - Clinical trials for Cardiovascular Diseases

Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia

PICk-UP
Start date: September 5, 2018
Phase: Phase 2
Study type: Interventional

This is a double blind randomised controlled feasibility study investigating the effect of postnatal enalapril on cardiovascular function in women who have had preterm pre-eclampsia. Participants will be randomised to 6 months of enalapril or placebo within 3 days of delivery. Cardiovascular function will be assessed using serial echocardiography and biomarkers.

NCT ID: NCT03466255 Completed - Clinical trials for Myocardial Infarction

Early Detection of Cardiovascular Disease

VIBE
Start date: December 6, 2016
Phase:
Study type: Observational

The investigators plan to evaluate the correlation between carotid plaque enhancement on Contrast-enhanced ultrasound (CEUS), significant coronary artery disease (CAD), and cardiovascular (CV) outcomes in a systematic manner. The investigators hypothesize that increased levels of CEUS-detected vulnerable carotid plaque will be predictive of CV risk determined by angiography and future cardiovascular events.

NCT ID: NCT03466151 Active, not recruiting - Clinical trials for Coronary Artery Disease

RESOLUTE ONYX China RCT Study

Start date: April 12, 2018
Phase: N/A
Study type: Interventional

It is a randomized controlled trial to evaluate the safety and efficacy of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in comparison with the Medtronic Resolute Integrity™ Zotarolimus-Eluting coronary stent system in the treatment of subjects eligible for percutaneous transluminal coronary angioplasty (PTCA) in China.

NCT ID: NCT03463941 Completed - Obesity Clinical Trials

Peer Support Dyads in Churches

Start date: January 5, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to explore how working with a partner can influence participation in a church wellness program. There are many different types of church wellness programs. Church members are more likely to participate and achieve goals in these programs when they have peer support. The researcher would like to know what African American men and women think about working with a support partner. This information will help researchers design better church wellness programs. The participants are being asked to take part in this research because the investigators believe that it is helpful to share feelings and thoughts about experiences working with a partner to achieve health goals. This knowledge will be used to create church wellness programs that will help African American men and women prevent disease and live healthier lives.

NCT ID: NCT03463486 Completed - Clinical trials for Cardiovascular Diseases

Current Outpatient Cardiac Rehabilitation in Austria

Start date: January 2005
Phase:
Study type: Observational [Patient Registry]

Aim of this study is to give evidence to outpatient cardiac rehabilitation in Austria. The database created in this context is supposed to pave the way as instrument to document and comprehend quality of outpatient cardiac rehabilitation in Austria as a key for quality management. Analyses of the created database should be made on a regular basis.

NCT ID: NCT03459638 Completed - Clinical trials for Cardiovascular Diseases

Periodontitis as Signal for an Underlying Disease

PACMEL
Start date: March 9, 2018
Phase:
Study type: Observational [Patient Registry]

This study investigates the differences between subjects with and without periodontitis in: the prevalence of (pre)diabetes mellitus, the risk of atherosclerotic cardiovascular disease, the prevalence of metabolic syndrome and the risk of obstructive sleep apnea syndrome.

NCT ID: NCT03459560 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants

Start date: December 20, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the effects of a fixed dose combination of enalapril (or valsartan), with hydrochlorthiazide, atorvastatin and acetylsalicylic acid (PolyPill) on primary and secondary prevention of cardiovascular disease in participants of Pars Cohort of Iran.

NCT ID: NCT03457662 Completed - Clinical trials for Cardiovascular Diseases

Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With PAD and Claudication

SMART-PAD
Start date: March 15, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this trial is to evaluate the safety and efficacy of sonodynamic therapy (SDT) on reducing atherosclerotic plaques inflammation among patients with symptomatic femoropopliteal peripheral artery disease.

NCT ID: NCT03456934 Completed - Growth Clinical Trials

Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease

BabyGrowth
Start date: August 7, 2017
Phase: N/A
Study type: Interventional

The primary objective of this study is to investigate if consumption of lower protein formula can slow the rate of weight gain of formula-fed infants between 3 and 12 months of age. Secondary objectives include investigation into whether infant nutrition and growth have an impact on later risk of obesity and cardiovascular disease.